Clinical data Keto-Mojo offers an FDA-cleared GK+ glucose and ketone meter paired with a HIPAA- and GDPR-compliant remote patient monitoring platform (MyMojoHealth), enabling real-time metabolic data sharing with clinicians. This supports opportunities to upsell SMBs and mid-market health systems seeking robust remote monitoring for type 2 diabetes, obesity, and metabolic-related conditions.

Clinical trial readiness Active in 100+ clinical trials across metabolic disease, neurology, and oncology signals high demand for scalable, compliant infrastructure. This presents sales openings to pharmaceutical groups, contract research organizations, and academic centers needing trial-ready patient data capture, monitoring, and interoperability.

Global reach Operating in 38+ countries with a growing private social community by Keto-Mojo, there is potential to partner with multinational health networks and insurers to broaden adoption, facilitate cross-border remote monitoring, and support population health initiatives focused on metabolic wellness.

Community and engagement Recent launch of Community by Keto-Mojo and the ongoing Spotlight on Keto Research newsletter indicate a strategy to build user engagement and adherence. This can be leveraged to position enterprise customers with patient/datient engagement programs, coaching services, and outcome-driven reimbursements.

Tech-enabled scale Tech stack emphasizes cloud, security, and marketing automation (AWS, SSO/CRM, HIPAA-compliant data flows, patient population management). This enables targeting health systems and payer organizations seeking scalable, compliant remote monitoring solutions with strong data analytics to drive outcomes and cost savings.